other_material
confidence high
sentiment neutral
materiality 0.55
Denali Capital extends business combination deadline to April 11 via $15K trust deposit
Semnur Pharmaceuticals, Inc.
- Deposited $15,063.74 into trust to extend deadline from March 11 to April 11, 2025.
- Funding via convertible promissory note from Scilex (SCLX) with principal up to $180,000.
- Note bears no interest, convertible into Class A shares at $10.00 per share upon closing.
- Remaining $59,545.08 under note available for future one-month extensions.
- Company is a blank check SPAC seeking a merger or acquisition.